AC-607

N/A

Report date: 2023/01/12 15:29:04

Base Information

Drug NameAC-607

Drug Alias NameAC607AC 607Allogeneic multipotent stromal cell treatment (AlloCure)Allogeneic multipotent stromal cell treatment-AlloCureAllogeneic stem cell therapy (AlloCure) +[7]

ClassificationCell and gene therapy > Cell therapy > Donor > AllogeneicCell and gene therapy > Cell therapy > Stem cell therapy > Mesenchymal stem cells therapyCell and gene therapy > Cell therapy > Source of cells > Bone Marrow-derived

Mechanisms of ActionCell replacementsImmunomodulatorsT lymphocytes inhibitors

TargetsNot applicable

Therapy Area/IndicationsKidney Tubular Necrosis, AcuteAcute Kidney Injury

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryCanadaUnited States

CombinationsNo

Global Highest StatusDiscontinued (Phase 2 Clinical)

Highest Status in ChinaN/A

Originator CompaniesAllocure Inc

China Registration ClassN/A

Develop Information

Active CompaniesN/A

Inactive CompaniesAllocure Inc

Active IndicationsN/A

Inactive IndicationsKidney Tubular Necrosis, AcuteAcute Kidney Injury

Other Information

ATC CodeN/A